These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 2813378)
1. Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors. Fleming TP; Matsui T; Molloy CJ; Robbins KC; Aaronson SA Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8063-7. PubMed ID: 2813378 [TBL] [Abstract][Full Text] [Related]
2. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation. Huang SS; Huang JS J Biol Chem; 1988 Sep; 263(25):12608-18. PubMed ID: 2842336 [TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy. Fleming TP; Matsui T; Aaronson SA Exp Gerontol; 1992; 27(5-6):523-32. PubMed ID: 1385192 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells. Potapova O; Fakhrai H; Baird S; Mercola D Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581 [TBL] [Abstract][Full Text] [Related]
5. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex. Hart KC; Xu YF; Meyer AN; Lee BA; Donoghue DJ J Cell Biol; 1994 Dec; 127(6 Pt 2):1843-57. PubMed ID: 7806564 [TBL] [Abstract][Full Text] [Related]
6. Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors. Garrett JS; Coughlin SR; Niman HL; Tremble PM; Giels GM; Williams LT Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7466-70. PubMed ID: 6095298 [TBL] [Abstract][Full Text] [Related]
7. The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation. Bejcek BE; Hoffman RM; Lipps D; Li DY; Mitchell CA; Majerus PW; Deuel TF J Biol Chem; 1992 Feb; 267(5):3289-93. PubMed ID: 1310684 [TBL] [Abstract][Full Text] [Related]
8. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction. Lee BA; Donoghue DJ J Cell Biol; 1992 Sep; 118(5):1057-70. PubMed ID: 1324943 [TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts. Cavari S; Ruggiero M; Vannucchi S Cell Biol Int; 1993 Aug; 17(8):781-6. PubMed ID: 8106075 [TBL] [Abstract][Full Text] [Related]
11. The sis gene and PDGF. Williams LT Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684 [TBL] [Abstract][Full Text] [Related]
13. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell. Kim HR; Upadhyay S; Korsmeyer S; Deuel TF J Biol Chem; 1994 Dec; 269(48):30604-8. PubMed ID: 7982979 [TBL] [Abstract][Full Text] [Related]
15. Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation. Lee BA; Donoghue DJ J Cell Biol; 1991 Apr; 113(2):361-70. PubMed ID: 1849139 [TBL] [Abstract][Full Text] [Related]
16. The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein. Xu YF; Meyer AN; Webster MK; Lee BA; Donoghue DJ J Cell Biol; 1993 Nov; 123(3):549-60. PubMed ID: 8227125 [TBL] [Abstract][Full Text] [Related]